Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study.
about
Serum markers in prostate cancer detectionAn Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.Clinical Utility of Biomarkers in Localized Prostate Cancer.The role of prostate cancer biomarkers in undiagnosed men.The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA iImproving multivariable prostate cancer risk assessment using the Prostate Health Index.Influence of age on seven putative prostate tumor markers: a cohort study in Chinese men.Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate CancerWhom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting.Clinical Validation of a Serum Protein Panel (FLNA, FLNB and KRT19) for Diagnosis of Prostate Cancer.
P2860
Q35042519-729E7737-1E3F-4694-A08B-058218B17BA9Q37691113-D860EA7A-ACFF-44B2-B6EE-0DAD6D098259Q38241107-9D41A97C-F732-4EA9-8648-F89CC4A11F07Q38792354-C5EF0A74-4161-4151-B275-501CBAAF7283Q39140686-25A475BF-2AAB-4958-953E-973424A9EDB3Q40267154-D2A726D0-3696-4EF7-ACB0-366617CEED4BQ40270088-47811A88-E4DD-4E43-97D1-98750F37D0CFQ40993267-8872BD39-9174-4E6F-B89B-1147213EDE61Q41191641-583B1F7A-74EF-4915-A7DE-9964B671C040Q47436741-A2B8D18F-E20D-445E-9A5E-BA9D708E34B4Q51781558-1EF90193-044F-41A6-8516-A859528FF2DCQ52569296-F230CEFB-FA00-40E1-9E29-7CB5919D6D31
P2860
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Clinical performance of serum ...... a multicentric European study.
@en
Clinical performance of serum ...... a multicentric European study.
@nl
type
label
Clinical performance of serum ...... a multicentric European study.
@en
Clinical performance of serum ...... a multicentric European study.
@nl
prefLabel
Clinical performance of serum ...... a multicentric European study.
@en
Clinical performance of serum ...... a multicentric European study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Clinical performance of serum ...... a multicentric European study
@en
P2093
Alexander Haese
Alexandre de la Taille
Giuliana Lista
Giulio Maria Gadda
Joan Palou Redorta
Markus Graefen
Nicolò Maria Buffi
Vittorio Bini
P2860
P304
P356
10.1111/BJU.12718
P50
P577
2015-03-26T00:00:00Z